Logo image of DEVS

DEVVSTREAM CORP (DEVS) Stock Fundamental Analysis

NASDAQ:DEVS - Nasdaq - CA2519361000 - Common Stock - Currency: USD

0.3298  -0.01 (-3%)

Fundamental Rating

0

Taking everything into account, DEVS scores 0 out of 10 in our fundamental rating. DEVS was compared to 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of DEVS have multiple concerns. DEVS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DEVS has reported negative net income.
DEVS had a negative operating cash flow in the past year.
DEVS had positive earnings in 4 of the past 5 years.
DEVS had a negative operating cash flow in each of the past 5 years.
DEVS Yearly Net Income VS EBIT VS OCF VS FCFDEVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

DEVS has a Return On Assets of -522.90%. This is amonst the worse of the industry: DEVS underperforms 96.39% of its industry peers.
Industry RankSector Rank
ROA -522.9%
ROE N/A
ROIC N/A
ROA(3y)2.16%
ROA(5y)N/A
ROE(3y)2.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DEVS Yearly ROA, ROE, ROICDEVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DEVS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DEVS Yearly Profit, Operating, Gross MarginsDEVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for DEVS has been reduced compared to 1 year ago.
The debt/assets ratio for DEVS is higher compared to a year ago.
DEVS Yearly Shares OutstandingDEVS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEVS Yearly Total Debt VS Total AssetsDEVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -39.38, we must say that DEVS is in the distress zone and has some risk of bankruptcy.
DEVS has a worse Altman-Z score (-39.38) than 96.39% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -39.38
ROIC/WACCN/A
WACCN/A
DEVS Yearly LT Debt VS Equity VS FCFDEVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.05 indicates that DEVS may have some problems paying its short term obligations.
DEVS has a worse Current ratio (0.05) than 96.39% of its industry peers.
DEVS has a Quick Ratio of 0.05. This is a bad value and indicates that DEVS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.05, DEVS is not doing good in the industry: 96.39% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
DEVS Yearly Current Assets VS Current LiabilitesDEVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

DEVS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -234.61%.
Measured over the past years, DEVS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -77.92% on average per year.
EPS 1Y (TTM)-234.61%
EPS 3Y-77.92%
EPS 5YN/A
EPS Q2Q%-104.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DEVS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DEVS Price Earnings VS Forward Price EarningsDEVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DEVS Per share dataDEVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DEVS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEVVSTREAM CORP

NASDAQ:DEVS (7/14/2025, 12:47:37 PM)

0.3298

-0.01 (-3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.41%
Inst Owner Change0%
Ins Owners7.06%
Ins Owner Change0%
Market Cap11.04M
AnalystsN/A
Price TargetN/A
Short Float %7.92%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.73
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS-0.58
TBVpS-0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -522.9%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.16%
ROA(5y)N/A
ROE(3y)2.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -39.38
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-234.61%
EPS 3Y-77.92%
EPS 5YN/A
EPS Q2Q%-104.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-127.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-116.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-116.65%
OCF growth 3YN/A
OCF growth 5YN/A